Press Releases

This appointment makes the Montreal site attractive to North American clients and boosts CiToxLAB’s expertise in preclinical development and regulatory affairs. CiToxLAB, a leading CRO in the field of non-clinical research, announces today that John...

Adocia’s BioChaperone Combo is the first product combining insulin Glargine with a fast-acting insulin analogPhase I/II clinical trial demonstrates proof of concept in patients with type 1 diabetes, showing that BioChaperone Combo acts faster and longer than Humalog Mix...

BANGKOK Feb. 25 2014 - UBM Asia is pleased to announce the launch of ASEANbeauty the only beauty trade event supported by the Thai Cosmetics Manufacturers Association. This is to be the premier international beauty trade show for South...

WASHINGTON: U.S. News & World Report publisher of Best Hospitals and Best Children's Hospitals today released its Best Nursing Homes 2014 highlighting the top nursing homes in every state and nearly 100 major metropolitan areas. Now in its sixth year...

Basel, Switzerland, February 21, 2014 - NBE-Therapeutics (“NBE”) today announced that it has presented the successful validation of its enzymatic SMAC™-Technology for the generation of potent next-generation antibody drug conjugates (ADCs) at the international World ADC summit 2014 in...

DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies Strasbourg, France, February 4, 2014 – Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today...

The agreement covers the creation and sale of rodent animal models, the sale of existing rodent animal models and sublicensing rightsParis, France, February 4, 2014 – Cellectis (Alternext: ALCLS), the genome engineering specialist, and genOway (Alternext: ALGEN), the animal...